Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Interview

Interview

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Cannabis
  • Exclusives
  • Guidance
  • Interview
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance

By Lara Goldstein
Today, 10:06 AM
(Part four of a four-part series) See previous stories in this series: 

ATAI

Read More
7 minute read
  • Cannabis
  • Exclusives
  • Interview
  • Markets
  • News
  • Penny Stocks
  • Small Cap

EXCLUSIVE: Sean ‘Diddy’ Combs’ Right-Hand Man Tarik Brooks Tells All, Why Combs Enterprises Is Getting Into Cannabis

By Javier Hasse
Today, 10:06 AM
This week, an entity owned and controlled by Sean “Diddy” Combs known as Combs Enterprises announced the signing of definitive agreements to acquire certain cannabis assets in Ne

CCHWF

Read More
3 minute read
  • Cannabis
  • Cryptocurrency
  • Exclusives
  • Interview
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says ‘Potential Reward Is Immeasurable’

By Javier Hasse
Today, 10:06 AM
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a general partner, Benzin

$USDT

Read More
7 minute read
  • Cryptocurrency
  • Exclusives
  • Fintech
  • Interview
  • Markets
  • Top Stories

How UX Network Offers Price, Speed That Make Ethereum Seem Like ‘Playground For Rich Kids’

By Justin Roberti
Today, 10:06 AM
In 2017, Block.one, led by Dan Larimer and Brendan Blumer, launched the Entrepreneur Operating System (EOS) protocol, one of the earliest "Ethereum Killers," aiming to support decentralized finance apps at enterprise scale for a global audience.

$ALGO

Read More
1 minute read
  • Interview
  • Media
  • Trading Ideas

Is The Stock Market Already Pricing In A Mild Recession? Benzinga TV Asks

By Asli Tolon Coskun
Today, 10:06 AM
On the Thursday (Nov. 3) episode of "Benzinga TV," host Mitch Hoch spoke to Adam Lampe, CEO and co-founder of Mint Wealth Management, about opportunities in the stock marke

AMZN

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Vuzix CEO, Paul Travers Now Interviewing On Benzinga’s Live YouTube TV

By Benzinga Newsdesk
Today, 10:06 AM
Click To Tune In Here... https://www.youtube.com/watch?v=ZOLgseiu2g8

VUZI

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Actinium Pharmaceuticals, Inc. Chairman & CEO, Sandesh Seth Tells Benzinga ‘We Don’t Need To Raise Cash Right Now’ Says Company Has Exciting Product Pipeline Coming

By Benzinga Newsdesk
Today, 10:06 AM
https://www.youtube.com/watch?v=nzT2jAbCzeI

ATNM

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Actinium Pharmaceuticals, Inc. Chairman & CEO, Sandesh Seth Tells Benzinga ‘Co Has Enough Capital To Take The Company To 2025’

By Benzinga Newsdesk
Today, 10:06 AM
https://www.youtube.com/watch?v=nzT2jAbCzeI

ATNM

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Actinium Pharmaceuticals, Inc. Chairman & CEO, Sandesh Seth Now Interviewing On Benzinga’s Live TV

By Benzinga Newsdesk
Today, 10:06 AM
Click To Tune In Here... https://www.youtube.com/watch?v=nzT2jAbCzeI

ATNM

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Actinium Pharmaceuticals, Inc. Chairman & CEO, Sandesh Seth To Appear On Benzinga’s Live TV At 11:05 a.m. ET

By Benzinga Newsdesk
Today, 10:06 AM
Click To Tune In Here... https://www.youtube.com/watch?v=nzT2jAbCzeI

ATNM

Posts navigation

Previous 1 … 10 11 12 … 116 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service